Proteins are macromolecules, which perform a large variety of functions. Most of them have only a single function, but an increasing number of proteins are being identified as multifunctional. Moonlighting proteins form a special class of multifunctional proteins. They perform multiple autonomous and often unrelated functions without partitioning these functions into different domains of the protein. Striking examples are enzymes, which in addition to their catalytic function are involved in fully unrelated processes such as autophagy, protein transport or DNA maintenance. In this contribution we present an overview of our current knowledge of moonlighting proteins and discuss the significant implications for biomedical and fundamental research.
The definition of moonlighting proteins
The first examples of moonlighting proteins were described in the late 1980s, when Piatigorsky and Wistow [1] reported that certain crystallins, structural proteins in the lens of the vertebrate eye, were well known enzymes. For example, duck ε-crystallin turned out to be lactate dehydrogenase [2] , whereas turtle τ-crystallin is the glycolytic enzyme α-enolase [3] . A metabolic role of these enzymes in the lens, where they accumulate to very high concentrations, is not likely [4] . Instead they probably have only a structural function in the lens. In line with this assumption is the observation that some crystallins are enzymatically inactive paralogs of these enzymes (see below) [5] [6] [7] .
To describe the phenomenon of moonlighting, Piatigorsky initially coined the term gene sharing [8] , but nowadays moonlighting is the generally used term [9] , in analogy to moonlighting people who have multiple jobs. Moonlighting proteins are very special multifunctional proteins, because they perform multiple autonomous, often unrelated, functions without partitioning these functions into different protein domains. Hence, proteins that have multiple functions as a result of gene fusion are excluded. The same is true for proteins that are translation products of different splice variants of the same gene. Another important criterion for a moonlighting protein is the independency of both functions, meaning that inactivation of one of the functions (e.g. by mutation) should not affect the second function and vice versa.
Moonlighting should also not be confused with pleiotropism. Pleiotropic effects generally are the result of inactivation of a single function, which is involved in multiple cellular processes, e.g. a protein that has multiple interaction partners in different pathways or an enzyme which is important in several metabolic pathways. Instead, moonlighting proteins perform multiple functions, which differ mechanistically.
Moonlighting proteins: widespread and involved in many processes
As illustrated in Table 1 , examples of moonlighting proteins have been described in many species including plants [10] , animals [11] , yeast [12] and prokaryotes [9, 13] . Although most examples of moonlighting proteins have been identified in yeast [12] , this is probably only due to the fact that these organisms are extensively studied. The currently known moonlighting functions are extremely diverse and are involved in a large range of biological functions (exemplified in Table 1 ). To illustrate their widespread occurrence and the diversity in functions, five characteristic examples of moonlighting proteins are detailed below.
Escherichia coli thioredoxin
The E. coli anti-oxidant protein thioredoxin is an example of a prokaryotic moonlighting protein [14] . Upon infection with the bacteriophage T7 E. coli thioredoxin forms a complex with T7 DNA polymerase, which results in enhanced T7 DNA replication [15, 16] , a crucial step in successful T7 infection. Thioredoxin binds to a loop in T7 DNA polymerase, thereby creating a sliding clamp that allows the polymerase to bind more strongly to the DNA [17] . The anti-oxidant function of thioredoxin is fully autonomous and completely independent of its function in T7 DNA replication [18, 19] , in which the protein most likely fulfils a structural role.
Pyruvate carboxylase in methylotrophic yeast
Pyruvate carboxylase is a highly conserved enzyme, which catalyzes the carboxylation of pyruvate into oxaloacetate, thereby replenishing the tricarboxylic acid cycle [20] . Surprisingly, in methylotrophic yeast species, such as Hansenula polymorpha and Pichia pastoris, pyruvate carboxylase is also essential for proper targeting and assembly of the peroxisomal protein alcohol oxidase (AO). AO, the first enzyme of methanol metabolism [21] , is a homooctameric flavoenzyme [22] . In wild type cells the bulk of this enzyme is present as enzymatically active AO octamers in the peroxisomal matrix. However, in cells lacking pyruvate carboxylase enzymatically inactive, FAD-lacking AO monomers accumulate in the cytosol, indicating that pyruvate carboxylase has a second fully unrelated function in assembly and import of a peroxisomal matrix protein [23] . How pyruvate carboxylase fulfils this function is yet unknown. As prescribed for a genuine moonlighting protein [24] , the function in AO import/assembly is fully independent of the enzyme activity of pyruvate carboxylase, because amino acid substitutions can be introduced that fully inactivate the enzyme activity of pyruvate carboxylase, without affecting its function in AO assembly and import. Conversely, mutations are known that fully block the function of pyruvate carboxylase in import and assembly of AO, but have no effect on the enzyme activity of the protein [24] .
Physcomitrella patens presenilin
Presenilin is the catalytic component of the multiprotein γ-secretase enzyme complex [25] , which cleaves important proteins such as Notch [26] and amyloid precursor protein (APP), proteins implicated in Alzheimer's disease [27] . Mammalian presenilin is suggested to have several moonlighting functions, but it is difficult to study these functions in mammals. To facilitate the analysis, the moss P. patens is used as a model organism, because this organism contains γ-secretase, but not Notch or APP. Upon deletion of the P. patens gene encoding presenilin phenotypic abnormalities were found, which strongly suggested that presenilin has a function in the cytoskeletal network of the moss [28] . This novel function is unrelated to the enzymatic activity of presenilin, because enzymatically inactive variants of presenilin could rescue the aberrant morphology. Interestingly an enzymatically inactive version of human presenilin could also rescue the phenotype upon introduction in P. patens. This suggests that presenilin may have an evolutionary conserved moonlighting function, which is present in plants as well as in mammals. [9] [10] [11] [12] 78] . For some examples (marked with *), there is data that strongly suggests that these proteins are genuine moonlighting proteins, but there is no conclusive experimental evidence yet that the multiple functions of these protein are indeed independent.
Cytochrome c
The mitochondrial intermembrane space protein cytochrome c is part of the electron transport chain. However, upon release into the cytosol the protein is important in apoptosis. Cytosolic cytochrome c forms a complex with the apoptotic protease-activating factor 1 (Apaf-1), which is the start of a signaling cascade that results in apoptotic cell death [29] . The redox and pro-apoptotic functions of cytochrome c are completely independent [30, 31] . It is possible to create a mutant cytochrome c variant that functions normally in respiration, but which is unable to bind to Apaf-1. Vice versa cytochrome c does not need to have a functional redox capacity to induce an apoptotic response. Hence, cytochrome c also has the characteristics of a true moonlighting protein.
STAT3
Recent data indicate that mammalian STAT3 represents a genuine moonlighting protein [32] . STATs are signal transducers and activators of transcription [33] . Phosphorylated STATs translocate to the nucleus, where they bind to the promoter regions of a specific set of genes to regulate their expression. The hormone leptin activates STAT3, which is important for the regulation of whole-body energy intake and metabolism. Wegrzyn et al. [34] showed that a portion of the cellular STAT3 protein is localized to mitochondria, where it plays a role in oxidative phosphorylation. In the absence of STAT3 mitochondrial oxidative phosphorylation is significantly reduced due to a decrease in the activities of complexes I and II of the electron transport chain. Because the levels of complex I and II proteins were normal in these cells, STAT3 most likely has no role in the transcriptional regulation of these proteins. This was further supported by the observation that transcriptionally inactive STAT3 variants were able to restore mitochondrial function. In addition, a STAT3 mutant has been identified that is unable to restore mitochondrial function, but still possessed transcriptional activity. Hence, inactivation of the function of STAT3 in transcriptional regulation does not influence its role in mitochondrial respiration and vice versa.
General features of moonlighting proteins
Many of the currently known moonlighting proteins are highly conserved enzymes, also called ancient enzymes. Especially enzymes involved in sugar metabolism appear to moonlight [2, 3, [35] [36] [37] [38] . It has been suggested that as many as 7 out of the 10 proteins in the glycolytic pathway and 7 out of the 8 enzymes of the tricarboxylic acid (TCA) cycle have a moonlighting function [11, 39] .
Why moonlighting functions are so frequently identified in highly conserved proteins is still very speculative. Possibly this is related to the fact that highly conserved proteins are present in many different organisms and hence there is a higher chance that moonlighting functions are identified for one of these proteins as compared to proteins that are present in only a few species [9, 40] . Moonlighting functions also seem to occur more often in proteins that are constitutively expressed at relatively high levels [41] . For these proteins the development of a novel function is not restricted to specific conditions. Although many moonlighting functions reside in highly conserved proteins, the presence of such a function cannot be predicted based on homology. For example, the yeast Saccharomyces cerevisiae contains two pyruvate carboxylases, which each share about eighty percent sequence identity with pyruvate carboxylase from H. polymorpha. Despite the high similarity between these proteins, neither one of the pyruvate carboxylases from S. cerevisiae can perform the moonlighting function of H. polymorpha pyruvate carboxylase in the assembly/ translocation of peroxisomal AO [42] . Pyruvate carboxylase from the methylotrophic yeast P. pastoris also shares about eighty percent sequence identity with pyruvate carboxylase from H. polymorpha. In contrast, it is capable of fulfilling the same moonlighting function as its counterpart in H. polymorpha [23, 43] .
Evolution of moonlighting proteins
It has been speculated that moonlighting possibly evolves as a way to expand the functional capabilities of an organism without the burden of an expanding genome [9] . However, this is not very likely as in many organisms large parts of the genome do not seem to have a function and thus there may be little selection pressure to limit genome size [44] .
Gancedo [12] presented a more plausible explanation and referred to the tinkerer's way of evolution [45] , which means that there is no end goal in evolution and that novel functions only develop by adapting existing ones. If a particular novel function results in an advantage for the organism, this function will be selected for during evolution.
For the development of a moonlighting function, a protein is proposed to have some innate compatibility for a new function [46] . Additional mutations, which augment the proteins ability to perform this novel function, are then subsequently selected for.
There are indications that a very limited number of mutations is sufficient to introduce a new moonlighting function. A good example is GroEL from Enterobacter aerogenes, a bacterium that lives in the saliva of antlions. Antlions are larvae of the Myrmeleontidae family that prey on other insects. They paralyse their prey by injecting a paralysing toxin produced by salivary bacteria. Yoshida et al. [47] identified the paralysing toxin in the saliva of Myrmeleon bore larvae as a homologue of GroEL, a well known molecular chaperone [48] . E. aerogenes GroEL and E. coli GroEL differ only by 11 amino acids [47] . Yet E. coli GroEL is not toxic, but E. aerogenes GroEL is. Mutational analysis revealed that only four amino acids were essential for toxicity. Because none of them were in proximity to the GroEL folding cage, these residues are not involved in the chaperone function of GroEL. Interestingly, a toxic E. coli GroEL variant could be constructed by introducing the corresponding residues in this protein. Hence, only four amino acid substitutions were sufficient to introduce a moonlighting function!
Moonlighting and gene duplication
The stress many people experience when combining two jobs may also be true for moonlighting proteins [49, 50] . For instance, the expression pattern required for one function may not be ideal for the other function. Also, a particular mutation may increase the efficiency of one function, but compromise the efficiency of the other one. In these cases it may be advantageous to distribute the original and moonlighting function over two genes by means of gene duplication.
An example is argininosuccinate lyase, the fourth enzyme of the urea cycle. In ducks and ostriches this enzyme is a moonlighting protein as it also serves as a crystallin in the eye lens [8, 51] . In chickens, however, the two functions of argininosuccinate lyase protein are performed by two highly homologous proteins. One of these is the enzymatically inactive form of the enzyme and functions as structural crystallin in the eye lens. The other is the enzymatically active enzyme that functions in the urea cycle. Consequently, unlike in ducks and ostriches, two genes are necessary in chickens to fulfil the function of the original one [8] .
Another example is galactokinase in the yeast species Kluyveromyces lactis and S. cerevisiae [52] . In K. lactis, this protein catalyzes the first step of the galactose utilization pathway and in addition acts as a transcriptional activator for itself and the other proteins of the galactose pathway [53, 54] . Its function as transcriptional activator is independent of its enzymatic function and vice versa as mutagenesis can inactivate either one without affecting the other. In S. cerevisiae the two functions of K. lactis galactokinase are however performed by two different proteins, which are highly homologous [55, 56] . S. cerevisiae galactokinase however has not completely lost its ability to activate transcription of the galactose pathway proteins [57, 58] .
Medical relevance
The complex phenotypes of several disorders, may be related to the involvement of moonlighting proteins [11] . Although there is insufficient evidence to support most of these claims, there are well studied examples of moonlighting proteins that could play a role in disease. Two of these are detailed below.
Dihydrolipoamide dehydrogenase (DLD)
Dihydrolipoamide dehydrogenase (DLD) is a mitochondrial enzyme that is a component of at least five different multienzyme complexes [50] . Due to its participation in these enzyme complexes DLD is critical for energy metabolism and redox balance. Deficiencies in DLD activity are associated with severe disorders in infancy, such as an inability to thrive, hypotonia and metabolic disorders. The severity of symptoms is however very variable and depends on the mutation present in the gene.
Under normal conditions DLD is predominantly present as active homodimers, which are in dynamic equilibrium with the inactive monomer [59] . However, under certain conditions, such as acidification of the mitochondrial matrix, the protein is mainly monomeric, resulting in a loss in DLD enzyme activity. Babady et al. [50] showed that mutations that destabilize the homodimer may have an additional effect, namely an increased ability of DLD to function as a protease due to enhanced exposure of a catalytic dyad at the dimer interface. This moonlighting proteolytic activity is independent of its enzymatic function. A single point mutation in the catalytic dyad, S456A, results in the complete loss of proteolytic activity without affecting enzymatic function. This moonlighting function of DLD may negatively contribute to the metabolic defects seen in some DLD patients.
Mycobacterium tuberculosis glutamate racemase (MurI)
The pathogenic bacterium M. tuberculosis is the primary cause of tuberculosis in humans [60] . This disease is highly infectious and can be lethal, if left untreated. Ciprofloxacin is a broad-spectrum antibiotic, which can be used to combat M. tuberculosis [61] . It stimulates the introduction of double-strand DNA breaks upon binding to a DNA gyrase. Unfortunately, however, a moonlighting function of the M. tuberculosis MurI protein counteracts the effects of ciprofloxacin. MurI is a glutamate racemase, which is an essential M. tuberculosis enzyme involved in cell wall (peptidoglycan) biosynthesis. It catalyzes the conversion of L-glutamate to D-glutamate [62] , a peptidoglycan building block. In several bacterial species, including M. tuberculosis [63] [64] [65] , MurI however can also function as DNA gyrase inhibitor, by reducing binding of gyrase to DNA. This second function is independent of its glutamate racemase enzymatic activity, hence it represents a moonlighting function [65] .
Overproduction of MurI, enzymatically active or not, protects M. tuberculosis against the action of the ciprofloxacin [65] , because MurI inhibits binding of gyrase to DNA and subsequent introduction of cytotoxic double-strand DNA breaks.
Moonlighting proteins are also suggested to play a role in host cell invasion [66, 67] . Due to their possible role in disease, enhancing or blocking moonlighting functions could be a target for future drug design. Such an approach would however require more knowledge of moonlighting functions in general and their molecular basis.
Moonlighting proteins in molecular life sciences
The existence of moonlighting functions is a major challenge in genome annotation. Even well studied proteins might harbor additional functions that have yet to be discovered. The discovery of many moonlighting functions has so far been entirely serendipitous [1, 23, 35, 47, 50] . A reason for this is that moonlighting functions are generally difficult to predict, because many functions do not depend on well known, conserved protein motifs [23, 50] . Additionally, moonlighting functions are often not conserved [42, 47, 49] . Examples exist where specific proteins have different moonlighting functions in different species. For instance, aconitase in S. cerevisiae has a second function in mitochondrial DNA (mtDNA) maintenance [35] , while in mammals [68] [69] [70] and in M. tuberculosis [71] it is involved in iron homeostasis. Aldolase is essential for the assembly and activity of the vacuolar H+-ATPase in yeast [36, 72] , but its actin binding capabilities are important for host cell invasion in Plasmodium falciparum and Plasmodium vivax [73] [74] [75] .
In addition to serendipitous discovery, moonlighting proteins have also been discovered using yeast two-hybrid assays [72] and proteomics [76] . A previous review has also suggested mass spectrometry as a tool for identifying novel moonlighting proteins [77] . A novel strategy to directly search for moonlighting functions in enzymes would be to compare the phenotypes of strains in which the enzyme is inactivated by a point mutation with strains in which the entire gene is deleted. In case of a gene encoding a moonlighting protein there should be a discrepancy between both phenotypes.
An important challenge is to understand how a moonlighting protein can perform such diverse functions. One strategy is to identify the residues which are essential for the moonlighting function. In some cases these residues are relatively easy to find. For instance, the toxic E. aerogenes GroEL differs only 11 amino acids with the non-toxic E. coli GroEL [47] . In this case it is very evident that (some of) these 11 residues must be important for the moonlighting activity. Although more challenging, it would be interesting if the amino acids crucial for the moonlighting function were also pinpointed in other moonlighting proteins.
Perspectives
At present it is still difficult to assess how abundant moonlighting proteins are. However, the fast growing number of identified moonlighting functions suggests that it is a general phenomenon in all kingdoms of life. Further research into moonlighting is certainly warranted as it will allow us to better understand the essence of protein function. What allows a protein to perform a particular function?
How do moonlighting functions evolve? Also, moonlighting functions create a whole new level of complexity in the cell. A moonlighting protein may link a metabolic pathway to a signaling pathway in a completely unexpected manner (e.g. very relevant in systems biology approaches). As a result, awareness of moonlighting is very important in many disciplines of life sciences.
Moonlighting is a phenomenon that illustrates nature's ingenuity. It is a source of inspiration that should remind scientists to always keep the unexpected in mind, even on familiar ground.
